Market News
Recent Developments:
New product launches/approval:
- On January 3, 2023, Convatec Group PLC, a medical device company, launched the U.S. ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, thus making it the simple dressing choice for wound management and skin protection.
- In October 2022, Healthium Medtech, a global medical devices company focused on surgical, post-surgical and chronic care, launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers.
- In April 2022, BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence (AI) approached to identify and develop transformative medicines in neuroscience and immuno-oncology, announced that the U.S. Food and Drug Administration (FDA) has approved IGALMI (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Acquisition and investment:
- In December 2021, Essity, a hygiene and health company, announced it had acquired the company Hydrofera, a developer of antibacterial wound dressings. The acquisition supports Essity's strategic priority to grow through acquisitions in medical solutions.
- In September 2021, Healthium Medtech, a global medical devices company focused on surgical, post-surgical and chronic care, announced the acquisition of CareNow Medical Private Limited, a global medical-technology company, strengthening its product portfolio with patented and differentiated products in the advanced wound management and infection prevention segments.
- In February 2021, the Digital Technology Supercluster invested US$ 2.5 Mn into a new US$ 3.1 Mn initiative, Telewound Care Canada, intended to aid wound patients access care virtually.
U.S.: 
U.K. : 
India :